15 Analysts Assess Tenet Healthcare: What You Need To Know
Portfolio Pulse from Benzinga Insights
Fifteen analysts have recently evaluated Tenet Healthcare (NYSE:THC), showing a range of sentiments from bullish to somewhat bullish. The average 12-month price target has increased by 11.98% to $162.6, with a high of $197.00 and a low of $112.00. Analysts have mostly raised their ratings and price targets, indicating positive sentiment. Tenet Healthcare has shown positive revenue growth and strong financial metrics, but its high debt-to-equity ratio poses potential challenges.
October 01, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have shown a predominantly bullish sentiment towards Tenet Healthcare, with an increase in the average price target to $162.6. The company's strong financial metrics are offset by a high debt-to-equity ratio.
The majority of analysts have raised their ratings and price targets for Tenet Healthcare, indicating a positive outlook. The increase in the average price target by 11.98% suggests confidence in the company's future performance. However, the high debt-to-equity ratio could pose financial challenges, which investors should monitor.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100